Low molecular weight heparins versus unfractionated heparin for thromboprophylaxis: a review of the cost-effectiveness
Membe SK, Nkansah E
Record ID 32011001248
English
Authors' recommendations:
No economic evaluation studies comparing LMWH with UH for prevention of VTE following major orthopedic surgery were identified. The results of the included economic evaluation studies support the cost-effectiveness of LMWH compared to UH in various medical inpatient populations, which may also be relevant to the orthopedic surgery patient population. The results of the reviewed studies are limited by variations in costing methods, quality and validity of clinical inputs used, analytical time horizon, study perspective, and assumptions, which are potential considerations for decision-making. It may not be appropriate to compare the results across the studies, and this report reviewed the cost-effectiveness of either LMWH or UH as demonstrated in the various studies.
Details
Project Status:
Completed
URL for project:
http://www.cadth.ca/media/pdf/L0121_LMWH_versus_UH.pdf
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Heparin
- Venous Thromboembolism
- Venous Thrombosis
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.